Abstract
Heat-labile enterotoxin (LT) of enterotoxigenic Escherichia coli (ETEC) is one of the major virulence factors for causing diarrhea in piglets, and LT is a strong immunogen. Thus, LT represents an important target for development of vaccines and diagnostic tests. In this study, bioinformatic tools were used to predict six antigenic B cell epitopes in the B subunit of LT protein (LTB) of ETEC strains. Then, seven antigenic B cell epitopes of LTB were identified by polyclonal antisera (polyclonal antibody (PAb)) using a set of LTB-derived peptides expressed as maltose-binding protein (MBP) fusion protein. In addition, one LTB-specific monoclonal antibody (MAb) was generated and defined its corresponding epitope as mentioned above. This MAb was able to specifically bind with native LT toxin and has no cross-reaction with LT-II (type II heat-labile enterotoxin), Stx1 (Shiga toxin I), Stx2 (Shiga toxin II), STa (heat-stable enterotoxin I), and STb (heat-stable enterotoxin II) toxins. Further, this MAb was able to interrupt LT toxin specific binding to GM1 receptor, indicating that the corresponding epitope is the specific binding region to GM1 receptor. Moreover, in vitro and in vivo assay showed that the MAb was able to neutralize t...Continue Reading
References
Sep 1, 1980·Journal of Clinical Microbiology·M K Gentry, J M Dalrymple
Dec 1, 1981·Journal of Bacteriology·T YamamotoA Kaji
Oct 23, 1997·Clinical Microbiology Reviews·M K Wolf
Mar 17, 2001·Scandinavian Journal of Immunology·M YamamotoH Kiyono
Apr 3, 2001·International Immunology·T O NasharR N Mitchell
Jun 24, 2004·Infection and Immunity·Emil M BerberovRodney A Moxley
Aug 12, 2004·Applied Biochemistry and Biotechnology·Tae-Jin KangMoon-Sik Yang
Jul 16, 2005·Clinical Microbiology Reviews·Firdausi QadriR Bradley Sack
Nov 24, 2005·Journal of Dental Research·G HajishengallisM W Russell
Jan 24, 2006·Infection and Immunity·Kenneth P AllenJames M Fleckenstein
Feb 13, 2007·Memórias do Instituto Oswaldo Cruz·Caroline A MenezesRoxane M F Piazza
Feb 23, 2007·Vaccine·Robin McKenzieGregory M Glenn
Feb 21, 2008·Alimentary Pharmacology & Therapeutics·H L DuPont
Nov 4, 2008·Journal of Bacteriology·Amber M JohnsonPhilip R Hardwidge
Feb 28, 2009·Nature Protocols·Lawrence A Kelley, Michael J E Sternberg
Sep 15, 2009·Lancet·Danzhen YouGareth Jones
Nov 4, 2009·Microbes and Infection·James M FleckensteinHans Steinsland
Feb 24, 2010·Protein Expression and Purification·Nguyen Hoang LocMoon-Sik Yang
May 15, 2010·Lancet·Robert E BlackUNKNOWN Child Health Epidemiology Reference Group of WHO and UNICEF
May 28, 2010·Clinical and Vaccine Immunology : CVI·Weiping Zhang, David H Francis
Sep 24, 2011·The Journal of General Virology·En-Cheng SunDong-Lai Wu
Jun 1, 2010·Toxins·Benjamin Mudrak, Meta J Kuehn
Jul 25, 2012·Veterinary Immunology and Immunopathology·J ZhaoD L Wu
Oct 30, 2012·Toxins·Letícia B RochaRoxane M F Piazza
May 22, 2013·Current Microbiology·Yufei FengDongfang Shi
Oct 23, 2013·PloS One·Chengxian ZhangUNKNOWN STa Toxoid Vaccine Consortium Group
Dec 18, 2013·Applied Microbiology and Biotechnology·L SunD L Wu
Apr 15, 2014·Protein Expression and Purification·Yufei FengDonglai Wu
Oct 11, 2014·Applied Microbiology and Biotechnology·Wenxin LiuDongfang Shi